Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.95
Delayed Data
As of Jul 02
 +1.12 / +19.21%
Today’s Change
3.71
Today|||52-Week Range
10.44
+52.41%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +331.65% increase from the last price of 6.95.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$0.00
Reporting Date
Jul 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.00%
 
 
 
 
 
 
Growthannually -16.13%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account